Ingredient guide · Ingredient reference

Vitamin D and AMH: what a fertility marker can and cannot show

Vitamin D and anti-Müllerian hormone, or AMH, have a complex research relationship. Supplementation has not consistently raised AMH, and an AMH change is not proof that egg quality or the chance of a live birth improved. Correcting vitamin D deficiency and interpreting an ovarian-reserve test are separate clinical questions.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

AMH is not a simple fertility score

ASRM distinguishes ovarian reserve, meaning egg quantity, from egg quality and reproductive potential. AMH is useful when estimating response to ovarian stimulation, but it is a poor stand-alone predictor of natural conception. A low result should be interpreted with age and the broader fertility assessment rather than treated as proof that pregnancy is impossible. [1]

The direction of change has differed across groups

A 2020 systematic review found inconsistent observational associations. Its intervention analysis reported lower AMH after vitamin D in women with polycystic ovary syndrome and higher AMH in ovulatory women without that condition. Those opposite directions make the claim that everyone should raise AMH with vitamin D particularly misleading. [2]

Later pooled evidence did not settle the question

A 2026 meta-analysis reported no significant overall AMH effect, although it described favorable findings for some other fertility measures. Differences in populations, interventions and outcomes limit a simple comparison between reviews. Neither finding provides an individual vitamin D dose that reliably restores ovarian reserve. [3][2]

Treat the actual problem

A clinician may recommend vitamin D for an established nutritional need while evaluating fertility separately. More vitamin D is not automatically better: excessive supplementation can cause high calcium and kidney complications. A supplement-induced laboratory change would still need to be connected to a meaningful reproductive outcome. [4][1]

Read an AMH result in context

Imagine AMH changes after a person starts vitamin D while undergoing fertility assessment. That sequence does not demonstrate that new eggs were created or egg quality improved. Discuss the test, age, ovulatory history and treatment goals with the fertility clinician rather than chasing a target number independently. [1][2]

Hypothetical example — interpret vitamin D and AMH evidence
FindingLimit
AMH changedNot a direct measure of egg quality
Different ovulatory groups responded differentlyNo universal direction of benefit
Pooled AMH effect was not significantNo reliable boosting claim
Vitamin D deficiency confirmedTreat nutritional need on its own merits
Vitamin D and AMH: what a fertility marker can and cannot show — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Testing and interpreting measures of ovarian reserve: a committee opinion (2020) - ASRM
    Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.
  2. The Association between Vitamin D and Anti-Müllerian Hormone: A Systematic Review and Meta-Analysis.
    Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.
  3. A meta-analysis of the literature evaluating the impact of vitamin D on female fertility and ovarian reserve function.
    Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.
  4. Vitamin D - Health Professional Fact Sheet
    Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.